about
[A survey about determinants of 2009 pandemic influenza A(H1N1) vaccination among French general practionners patients. Motivac study].Patient-physician agreement on tobacco and alcohol consumption: a multilevel analysis of GPs' characteristics.Impact of a printed decision aid on patients' intention to undergo prostate cancer screening: a multicentre, pragmatic randomised controlled trial in primary careTime and feasibility of prevention in primary care.Disengagement of general practitioners in cervical cancer screening.No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.Primary prevention of cardiovascular disease: More patient gender-based differences in risk evaluation among male general practitioners.General practitioners' relationship with preventive knowledge: a qualitative study.Factors associated with GPs' knowledge of their patients' socio-economic circumstances: a multilevel analysis.Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.Are primary-care physician practices related to health behaviors likely to reduce social inequalities in health?Level of agreement between physician and patient assessment of non-medical health factors.Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study.Contextual determinants of participation in cervical cancer screening in France, 2010.The organization of the health care provider's practice influenced patient participation in research: a multilevel analysis.[Factors associated with the lack of proposition for HIV-AIDS and hepatitis B and C screening to underprivileged immigrants].The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control studyTailored-Dose Baclofen in the Management of Alcoholism: A Retrospective Study of 144 Outpatients Followed for 3 Years in a French General PracticeValidity and measurement invariance across sex, age, and education level of the French short versions of the European Health Literacy Survey QuestionnaireAccumulation of unhealthy behaviors: Marked social inequalities in men and women.[Vaccination against hepatitis B in children: survey on knowledge, opinions, and practices of general practitioners in Île-de-France in 2009][Gynaecologic follow up, physicians involved and cervical smears: An accumulation of social disparities]Corrigendum: Level of agreement between physician and patient assessment of non-medical health factorsValidation of the French version of the Functional, Communicative and Critical Health Literacy scale (FCCHL)[General Practitioners and Physical Activity Counselling: from Evidence to Practice Contingencies]Titrated baclofen for high-risk alcohol consumption: a randomized placebo-controlled trial in out-patients with 1-year follow-upValidity of the French version of the Autonomy Preference Index and its adaptation for patients with advanced cancerGeneral practitioners who never perform Pap smear: the medical offer and the socio-economic context around their office could limit their involvement in cervical cancer screeningReply to comments on the Bacloville trial
P50
Q30412332-723390DC-652A-4057-9EE2-9A4B481BDE08Q35200901-4545F947-F846-4809-8004-EE50D00F7939Q35534206-9989B846-AA9D-4B12-80E8-5FF14CA76DBDQ38998974-223B0BF9-65D0-4F81-8487-6ED1B9EB1F56Q40251703-A90D0B30-202F-482E-B55E-98271113509CQ40314455-E629FBFF-85B5-407A-A18A-A75D4E4FFED0Q40510895-2A11652F-66AF-499C-BC36-465DEF5CB062Q40561101-5DC0CEBB-BA0C-4B2D-8277-4CCA16B8DD17Q40603089-5F690EAA-F1E7-4ACC-9ABF-4A4FE6EEF3E5Q42640821-14D646A2-F393-4FCB-AC80-97C665028B5BQ47439578-038123A0-83FE-4051-8A0F-DC067C061ED0Q47551114-9CC7B097-3DD2-4521-B50A-52AC821836CFQ47968139-56A1B355-1BA2-4909-8B5B-ECC52F71BF9AQ50424425-21EA6F93-65FB-4444-884F-8BB8259EDC57Q51275639-68940BBF-64A8-4A83-83D0-70C68497B4F0Q54110381-1D72D664-9B0A-4C97-B22B-629A697963D8Q57281719-EAC1D312-85D4-4122-BC24-59D773CE3C2CQ57817633-93A317A0-8C27-4B3D-B3AA-8B24F617263FQ60046338-015B6366-68E0-4676-B241-A5494CF3894CQ64923120-1E40C035-5E19-4B43-B869-022595F315CAQ83157592-BAEC3130-F1E8-48C3-9BA5-7BF8354D84BCQ87436446-22B14E1F-76A2-4C90-9E37-C4818F35189EQ88371133-75EABD9F-6DF1-4AEE-AC77-67725194E7BAQ88661341-646EC585-EAB7-46D8-908F-066CD35D2FA6Q89939562-60EB39A6-E9FB-4A45-8E40-EA0DC918BAAFQ91949411-8AAFBA5D-C70E-4EC5-A55D-E69DE811F285Q92626847-374ECAD0-352D-433F-A586-ACB4ED9A5320Q92643689-93ED7DB9-7030-4C3F-AC48-1B452D3A4650Q94507804-564BE5D2-AE80-4E00-A21C-0AA710222955
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
L Rigal
@en
L Rigal
@nl
type
label
L Rigal
@en
L Rigal
@nl
prefLabel
L Rigal
@en
L Rigal
@nl
P31
P496
0000-0001-6807-2738